Literature DB >> 7737562

Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells.

T Mothes1, U Bendix, C Pfannschmidt, I Lehmann.   

Abstract

Expression of major histocompatibility (MHC) class II molecules by enterocytes is known to be enhanced in coeliac disease and other disorders characterised by intestinal inflammation--an effect thought to be mediated via intestinal lymphocytes. To investigate if food peptides can exert direct effects on class II expression, the influence of gliadins, casein, and beta lactoglobulin on an intestinal epithelial cell line (HT-29) was examined in the absence of immune cells. Class II expression was determined by flow cytometry and immunofluorescence microscopy using antibodies against the beta chain of all products of the gene subregions DR, DQ, and DP. MHC expression was low in HT-29 cells but could be stimulated by interferon gamma. Tryptin digested gliadin had no effect on class II expression. In the presence of interferon gamma, however, it was able to amplify MHC class II expression to mean (SEM) 150 (4)%. Casein exerted a similar effect (160 (14)%), but undigested gliadin, tryptin digested casein, and beta lactoglobulin had no influence. The observations suggest that within the concert of cytokine mediated interactions between enterocytes and lymphocytes, some dietary peptides could upregulate the presentation of food antigens, leading to a more efficient stimulation of lymphocytes, which in the case of coeliac disease might result in damage to the enterocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737562      PMCID: PMC1382495          DOI: 10.1136/gut.36.4.548

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease.

Authors:  J R Lowes; P Radwan; J D Priddle; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

2.  Mucosal digestion studies of whole gliadin fractions in coeliac disease.

Authors:  H J Cornell
Journal:  Ann Clin Biochem       Date:  1990-01       Impact factor: 2.057

3.  Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

Authors:  S Fais; L Maiuri; F Pallone; M De Vincenzi; G De Ritis; R Troncone; S Auricchio
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

4.  Large-scale preparation of gliadin proteins.

Authors:  A L Patey; D J Evans
Journal:  J Sci Food Agric       Date:  1973-10       Impact factor: 3.638

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease.

Authors:  L Mayer; D Eisenhardt; P Salomon; W Bauer; R Plous; L Piccinini
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

7.  Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies.

Authors:  L Madrigal; S Lynch; C Feighery; D Weir; D Kelleher; C O'Farrelly
Journal:  J Immunol Methods       Date:  1993-02-03       Impact factor: 2.303

8.  Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro.

Authors:  C P Kelly; J C O'Keane; J Orellana; P C Schroy; S Yang; J T LaMont; H R Brady
Journal:  Am J Physiol       Date:  1992-12

9.  Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease.

Authors:  B Crotty; W M Rosenberg; J K Aronson; D P Jewell
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  1 in total

1.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.